Aromatic Beta-Blocker Atenolol from China
Atenolol is a synthetic aromatic beta-blocker drug used primarily for treating hypertension and angina. It falls under HTS 2942.00.05.00 as an aromatic organic compound classified as a drug, distinct from standard pharmaceuticals in Chapters 29 or 30. This code applies to specific aromatic or modified aromatic drugs not covered elsewhere.
Duty Rate — China → United States
31.5%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Verify drug status with FDA registration and provide Certificate of Analysis confirming aromatic structure
• Ensure compliance with DEA scheduling if applicable; avoid misclassification as Chapter 30 finished dosage forms
• Include stability data for transport as per Chapter 29 note (f) to prevent reclassification